Centers of Excellence Designations, Clinical Outcomes, and Characteristics of Hospitals Performing Percutaneous Coronary Interventions

Eitemau Tebyg

• Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009–2016
  gan: Dayoub, Elias J., et al.
  Cyhoeddwyd: (2019)
• Variability in Reported Percutaneous Coronary Intervention Mortality Among Physicians Practicing at Multiple Sites in New York State
  gan: Yang, Nancy, et al.
  Cyhoeddwyd: (2020)
• Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists
  gan: Khatana, Sameed Ahmed M., et al.
  Cyhoeddwyd: (2018)
• Federal Payments for Coronary Revascularization Procedures Among Dual Enrollees in Medicare Advantage and the Veterans Affairs Health Care System
  gan: Dayoub, Elias J., et al.
  Cyhoeddwyd: (2020)
• Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
  gan: Dayoub, Elias J., et al.
  Cyhoeddwyd: (2021)